The diagnostic and prognostic value of glial fibrillary acidic protein in traumatic brain injury: a systematic review and meta-analysis
- 7 May 2022
- journal article
- research article
- Published by Springer Nature in European Journal of Trauma and Emergency Surgery
- Vol. 49 (3) , 1235-1246
Abstract
Objectives Over the years, blood biomarkers have been extensively applied for diagnostic and prognostic assessment of traumatic brain injury (TBI). Herein, we conducted a meta-analysis to evaluate the diagnostic and prognostic value of glial fibrillary acidic protein (GFAP) for TBI patients. Methods The online databases, including PubMed, Embase, Cochrane Library, CNKI, and WFSD, were systematically retrieved from inception until May 2021. The RevMan 5.3 software and Stata 15 were used to conduct data analysis. Results A total of 22 eligible studies comprising 3709 patients were included in this meta-analysis. The pooled results indicated that serum GFAP had a diagnostic value in detecting traumatic intracranial lesions (AUC 0.81; 95% CI 0.77–0.84; p < 0.00001). The pooled sensitivity and specificity were 0.93 (95% CI 0.81–0.98), and 0.66 (95% 0.53–0.77; p < 0.00001), respectively. For assessment of unfavorable outcome, the pooled sensitivity, specificity and AUC value were 0.66 (95% CI 0.54–0.76; p < 0.00001), 0.82(95% CI 0.72–0.90; p < 0.00001), and 0.82 (95% CI 0.76–0.88; p < 0.00001), respectively. Besides, GFAP exhibited a significant value in predicting mortality (AUC 0.81; 95% CI 0.77–0.84; p < 0.00001), with high sensitivity and specificity (0.86, 95% CI 0.79–0.92, p < 0.00001, and 0.66, 95% CI 0.52–0.77, p < 0.00001). The subgroup analysis indicated that the type of TBI and cut-off value were potential sources of heterogeneity, which influenced the pooled AUC values for mortality prediction. Conclusions Our meta-analysis indicated that GFAP had diagnostic and prognostic value for TBI patients, especially during the early TBI.Keywords
Funding Information
- the Jiangsu Key Laboratory of Experimental & Translational Non-coding RNA Research (201902)
- Hospital Level Support Projects (Fcjs202050)
This publication has 30 references indexed in Scilit:
- The accuracy of glial fibrillary acidic protein in acute stroke differential diagnosis: A meta-analysisScandinavian Journal of Clinical and Laboratory Investigation, 2013
- GFAP and S100B in the acute phase of mild traumatic brain injuryNeurology, 2012
- QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy StudiesAnnals of Internal Medicine, 2011
- GFAP and S100B are biomarkers of traumatic brain injuryNeurology, 2010
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLOS Medicine, 2009
- Glial Fibrillary Acidic Protein is Highly Correlated With Brain InjuryJournal of Trauma: Injury, Infection & Critical Care, 2008
- Traumatic Brain Injuries in a Well-Defined Population: Epidemiological Aspects and SeverityJournal of Neurotrauma, 2007
- Increased serum-GFAP in patients with severe traumatic brain injury is related to outcomeJournal of the Neurological Sciences, 2006
- GFAP Versus S100B in Serum after Traumatic Brain Injury: Relationship to Brain Damage and OutcomeJournal of Neurotrauma, 2004
- An acidic protein isolated from fibrous astrocytesBrain Research, 1971